Breast cancer adjuvant therapy use increases in the US

Author：  

Publisher： Adis International

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.367, 2002-01, pp. : 6-6

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Use of LHRH-agonists as adjuvant therapy for breast cancer

By Cuzick Jack  

Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 8, 2008-08 ,pp. : 1065-1071

Informa Healthcare

Access to resources Recommend Favorite

Extend use of adjuvant therapy in breast cancer?

By  

Inpharma, Vol. 1, Iss. 1277, 2001-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

Aminoglutethimide adjuvant therapy in breast cancer

By  

Inpharma, Vol. 1, Iss. 1322, 2002-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

Controversies in breast cancer: adjuvant and neoadjuvant therapy

By Montemurro Filippo   Redana Stefania   Valabrega Giorgio   Aglietta Massimo  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 7, 2005-06 ,pp. : 1055-1072

Informa Healthcare

Access to resources Recommend Favorite

Adjuvant breast cancer therapy found lacking in Italy

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 420, 2003-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite